Article
The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis
1 Jan 2016
Abstract excerpt
Preimplantation Genetic Diagnosis and Screening (PGD/PGS) for monogenic diseases and/or numerical/structural chromosomal abnormalities is a tool for embryo testing aimed at identifying nonaffected and/or euploid embryos in a cohort produced during an IVF cycle. A critical aspect of this technology is the potential detrimental effect that the biopsy itself can have upon the embryo. Different embryo biopsy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
